What's New
´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Symposium ¾È³»-¾à¹°¿ªÇÐ ¹× ¾à¹°°æÁ¦ÇÐ[6/8]
°ü¸®ÀÚ | 2002-01-02 ¿ÀÈÄ 4:52:12 |  Á¶È¸ 2890

<2001³âµµ ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èSymposium - ¾à¹°¿ªÇÐ ¹× ¾à¹°°æÁ¦ÇÐ -

- ÀϽÃ: 2001³â 6¿ù8ÀÏ (±Ý)
- Àå¼Ò: ¼­¿ï´ëº´¿ø ÀÓ»óÀÇÇבּ¸¼Ò ´ë°­´ç

08:30 - 09:00 µî·Ï
09:00 - 09:10 °³È¸»ç ȸÀå Çã°©¹ü
<Ư°­>
ÁÂÀå: ¿¬¼¼ÀÇ´ë Çã°©¹ü
09:10 - 09:40 Trial Simulation ¼­¿ïÀÇ´ë ÀåÀÎÁø
ÁÂÀå: °¡Å縯ÀÇ´ë ±èÈƱ³
09:40 - 10:10 PAI-1 »ý¼º¿¡ ´ëÇÑ Adrenal Steroid¿Í Angiotensin IIÀÇ »ó½ÂÀû È¿°ú °¡Å縯ÀÇ´ë ±è°æ¼ö

10:10 - 10:30 ÈÞ½Ä

I ¾à¹°°æÁ¦ÇÐ
ÁÂÀå: ¼­¿ïÀÇ´ë ½Å»ó±¸
10:30 - 10:50 ¾à¹°°æÁ¦ÇÐÀÇ °³³ä ÇѾçÀÇ´ë ¹è»óö
10:50 - 11:40 Cost-Effectiveness Analysis Aslam H. Anis
11:40 - 12:00 ±¹³» Study ¿¹ ÇѾçÀÇ´ë À±Çü¶õ
12:00 - 12:10 ÀÓ½ÃÃÑȸ

12:10 - 13:30 Á¡½É½Ä»ç

II ¾à¹°¿ªÇÐ
<Ư°­>
ÁÂÀå: ¿¬¼¼ÀÇ´ë ±è°æȯ
13:30 - 14:20 The Continuum of Postmarketing Drug Surveillance: From Early Signals to Action Andy Stergachis

<ÀÚ¹ßÀû ÀÌ»ó¹ÝÀÀº¸°íü°è>
ÁÂÀå: ¼­¿ïÀÇ´ë ¹Úº´ÁÖ
14:20 - 14:40 ±¹³»ÇöȲ°ú Á¤ºÎÀÇ °èȹ ½Ä¾àû ÃÖ¼ö¿µ
14:40 - 15:00 º´¿ø³» ÀÌ»ó¹ÝÀÀ ¸ð´ÏÅ͸µ ½Ã¹ü»ç¾÷ ¿¬¼¼ÀÇ´ë 俵¹®
15:00 - 15:20 Á¦¾à¾÷°èÀÇ ÀÔÀå MSD ÀÌ¿ø½Ä
15:20 - 15:40 ¾à¹°¿ªÇÐ ¿¬±¸»ç·Ê Á¦ÁÖÀÇ´ë ¹èÁ¾¸é

15:40 - 16:00 ÈÞ½Ä

<ÀǾàÇ° Àç½É»çÁ¦µµ>
ÁÂÀå: ÀÎÇÏÀÇ´ë ³ëÇü±Ù
16:00 - 16:20 Àç½É»çÁ¦µµÀÇ ¹è°æ°ú ¿î¿µ»óȲ ½Ä¾àû È«¼ø¿í
16:20 - 16:40 Àç½É»çÁ¦µµÀÇ ¹®Á¦Á¡°ú °³¼±¹æ¾È ¼­¿ïÀÇ´ë ¹Úº´ÁÖ
16:40 - 17:00 Á¦¾à¾÷°èÀÇ ÀÔÀå Çѱ¹Bayer Áöµ¿Çö
17:00 - 17:20 ±¹³» PMS ¿¬±¸»ç·Ê ¿ï»êÀÇ´ë ±è¿µ½Ä
17:20 - 17:40 Åä·Ð ÁÂÀå: ¹Úº´ÁÖ, ³ëÇü±Ù

*°ü·ÃURL : http://www.kscpt.org/HOME/kscpt/kscpt01.nsf/webframe?openframeset